These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4368854)

  • 1. Juvenile GM1 gangliosidosis. Occurrence with absence of two beta-galactosidase components.
    Lowden JA; Callahan JW; Norman MG; Thain M; Prichard JS
    Arch Neurol; 1974 Sep; 31(3):200-3. PubMed ID: 4368854
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on GM1-gangliosidosis, type II.
    Patel V; Goebel HH; Watanabe I; Zeman W
    Acta Neuropathol; 1974; 30(2):155-73. PubMed ID: 4217089
    [No Abstract]   [Full Text] [Related]  

  • 3. GM1-ganglioside beta-galactosidase in leukocytes and cultured fibroblasts.
    Raghavan SA; Gajewski A; Kolodny EH
    Clin Chim Acta; 1977 Nov; 81(1):47-56. PubMed ID: 411612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An electrophoretic variant of beta-galactosidase with altered catalytic properties in a patient with GM1 gangliosidosis.
    Norden AG; O'Brien JS
    Proc Natl Acad Sci U S A; 1975 Jan; 72(1):240-4. PubMed ID: 804170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localized beta-galactosidase deficiency. Occurrence in cerebellar ataxia with myoclonus epilepsy and macular cherry-red spot--a new variant of GM1-gangliosidosis?
    Yamamoto A; Adachi S; Kawamura S; Takahashi M; Kitani T
    Arch Intern Med; 1974 Oct; 134(4):627-34. PubMed ID: 4278184
    [No Abstract]   [Full Text] [Related]  

  • 6. GM3 (hematoside) sphingolipodystrophy.
    Max SR; Maclaren NK; Brady RO; Bradley RM; Rennels MB; Tanaka J; Garcia JH; Cornblath M
    N Engl J Med; 1974 Oct; 291(18):929-31. PubMed ID: 4213132
    [No Abstract]   [Full Text] [Related]  

  • 7. Enzyme histochemical and ultrastructural alterations in the brains of Friesian calves with GM1 gangliosidosis.
    Sheahan BJ; Donnelly WJ
    Acta Neuropathol; 1974; 30(1):73-84. PubMed ID: 4217088
    [No Abstract]   [Full Text] [Related]  

  • 8. Sphingolipidoses in Turkey.
    Ozkara HA; Topçu M
    Brain Dev; 2004 Sep; 26(6):363-6. PubMed ID: 15275696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-galactosidase in tissue culture derived from human skin and bone marrow. Enzyme defect in GM1 gangliosidosis.
    Sloan HR; Uhlendorf BW; Jacobson CB; Fredrickson DS
    Pediatr Res; 1969 Nov; 3(6):532-7. PubMed ID: 5361691
    [No Abstract]   [Full Text] [Related]  

  • 10. Lactosylceramide beta-galactosidase in human sphingolipidoses. Evidence for two genetically distinct enzymes.
    Tanaka H; Suzuki K
    J Biol Chem; 1975 Mar; 250(6):2324-32. PubMed ID: 803971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GM1-gangliosidosis without chondrodystrophy or visceromegaly. B-galactosidase deficiency with gangliosidosis and the excessive excretion of a keratan sulfate.
    Wolfe LS; Callahan J; Fawcett JS; Andermann F; Scriver CR
    Neurology; 1970 Jan; 20(1):23-44. PubMed ID: 4243740
    [No Abstract]   [Full Text] [Related]  

  • 12. [Enzyme diagnostics in lysosomal diseases with emphasis on sphingolipidoses].
    Dreyfus JC; Poenaru L
    Arch Fr Pediatr; 1975; 32(6):503-14. PubMed ID: 810108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Krabbe's globoid cell leucodystrophy. Studies on galactosylceramide beta-galactosidase and non-specific beta-galactosidase of leucocytes, cultured skin fibroblasts, and amniotic fluid cells.
    Besley GT; Bain AD
    J Med Genet; 1976 Jun; 13(3):195-9. PubMed ID: 819652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme defects in the sphingolipidoses and their application to diagnosis.
    Brady RO
    Ann Clin Lab Sci (1971); 1972; 2(4):285-94. PubMed ID: 4342099
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of the properties and bile salt specificities of galactosylceramide and lactosyl ceramide beta-galactosidase activities in human leucocytes and fibroblasts.
    Poulos A; Beckman K
    Clin Chim Acta; 1980 Feb; 101(2-3):277-85. PubMed ID: 6766828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid hexosaminidase activity in Tay-Sachs and Sandhoff-Jatzkewitz diseases.
    Tomasi LG; Fukushima DK; Kolodny EH
    Neurology; 1974 Dec; 24(12):1158-65. PubMed ID: 4280528
    [No Abstract]   [Full Text] [Related]  

  • 17. Enzymic differentiation between different types of Tay-Sachs disease of similar clinical appearance.
    Clausen J; Melchior JC; Paerregaard P
    Eur Neurol; 1972; 7(1):56-64. PubMed ID: 4336274
    [No Abstract]   [Full Text] [Related]  

  • 18. Leukocyte -galactosidase activity in GM 1 -gangliosidosis.
    Young E; Ellis RB; Patrick AD; Singer HS; Schafer IA
    Pediatrics; 1972 Sep; 50(3):502-3. PubMed ID: 5056438
    [No Abstract]   [Full Text] [Related]  

  • 19. [Lysosomal beta-galactosidase properties and the molecular genetics of GM1 gangliosidosis].
    Vel'tishchev IuE; Kalaidzhieva LV
    Vopr Med Khim; 1979; 25(6):709-15. PubMed ID: 117628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study on enzyme activities of some sphingolipidoses.
    Ozkara HA; Arikan MC; Topçu M; Emre S; Renda Y
    Turk J Pediatr; 1994; 36(3):215-21. PubMed ID: 7974812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.